Cargando…
Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755914/ https://www.ncbi.nlm.nih.gov/pubmed/36343097 http://dx.doi.org/10.1002/psp4.12873 |
| _version_ | 1784851526452248576 |
|---|---|
| author | Gieschke, Ronald Carr, Robert |
| author_facet | Gieschke, Ronald Carr, Robert |
| author_sort | Gieschke, Ronald |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9755914 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97559142022-12-19 Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses Gieschke, Ronald Carr, Robert CPT Pharmacometrics Syst Pharmacol Perspectives John Wiley and Sons Inc. 2022-11-07 2022-12 /pmc/articles/PMC9755914/ /pubmed/36343097 http://dx.doi.org/10.1002/psp4.12873 Text en © 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Perspectives Gieschke, Ronald Carr, Robert Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses |
| title | Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses |
| title_full | Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses |
| title_fullStr | Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses |
| title_full_unstemmed | Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses |
| title_short | Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses |
| title_sort | conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses |
| topic | Perspectives |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755914/ https://www.ncbi.nlm.nih.gov/pubmed/36343097 http://dx.doi.org/10.1002/psp4.12873 |
| work_keys_str_mv | AT gieschkeronald conceptualandorganizationalbarrierstoquantitativesystemspharmacologymodelingofpathophysiologicalsystemicdrughypotheses AT carrrobert conceptualandorganizationalbarrierstoquantitativesystemspharmacologymodelingofpathophysiologicalsystemicdrughypotheses |